Global Medical Forum Foundation

Day Three • Wednesday, 19 September 2001 • The Social Implications of Healthcare Innovation

The morning Plenary Meeting on Day Three of the Forum will take a comparative approach to the healthcare debate by examining the many paradigms, both governmental and industrial, of innovation and its uses worldwide.

Many models have been tried and implemented. On a scientific level, conventional wisdom has propagated the notion that, in general, human disease and its effects are the same from society to society. The resulting usage and development of innovative healthcare technologies has followed this same line.

In the afternoon, the Main Speakers and panel will look in more detail at the specific relationships currently determining the global introduction of new technologies.

During both morning and afternoon, the Main Speakers at the Plenary will examine the social implications of innovation from several different perspectives in order to answer the following core questions:

Is there one best way forward for dealing with illness worldwide, or does each society have to find its own system and paradigm of healthcare and healthcare delivery and innovation?

What are the ethical issues involved in the paradigm choice from society to society? Can the role of the marketplace, whether public or private, be denied in the matter of choice?

It is the view of the Forum, that only through this type of open, honest, and direct communication can a new and beneficial paradigm of healthcare be discovered.

Site Links

Executive Summary
Forum Goals
GMF II Program
Key Management

Forum Organization
Location of the Forum
Organization & Strategy
GMF I Activities

Day One
Day Two
Day Three
Day Four

Contact the Foundation

07:30 hrs		Speakers' Breakfast Hotel Saratz, Pontresina



09:30 - 12:00		Plenary Session: The Healthcare Paradigm of the Future 1. The Evolving State of the Healthcare Market in the United States Dr. Robert Laszewski; President, Health Policy and Strategy Associates, Inc. (HPSA) and National Advisor on Health Policy Issues, Ernst & Young 2. Healthcare on Demand H.E. Mr. Ahmed Al Badi; Former Minister of Health, The United Arab Emirates Past President, The World Health Assembly 3. The Relationship of the University to Society and Innovation Dr. Gary Stiles; Chief of Medicine, Duke University Medical Center 4. Corporations and Governments Prof. Bernhard Scheuble; Chairman and CEO, Merck KGaA 5. Will Consumerism or Science Change Medicine? Dr. Kenneth J. Conway; President for Predictive Medicine, Millennium Pharmaceuticals Panel Members: Dr. Derek Yach; Executive Director, The World Health Organization Mrs. Frances Charlesworth; Director of Global Government Affairs and Policy, AstraZeneca PLC Dr. Gerhard Schmid; Director, Münich Reinsurance Company



12:30		Lunch



14:00 - 16:30		Plenary Session: First World, Third World: The Place of Innovation 1. First World: How Can the Government Facilitate Innovation? Dr. Jane Henney; Former Commissioner, Food & Drug Administration, USA Senior Scholar, Association of Academic Health Centers 2. The Role of Technology in Medicine Dr. Barbara McNeil; Professor of Health Policy, Harvard Medical School 3. Technology and the Developing World Dr. Beat Richner; Professor of Pediatrics, University of Pnom Penh, Cambodia 4. The Role of Innovation in Healthcare Today and Its Possible Impact on the Arab Region Dr. Nabil Kronfol; Chairman of the Technical Committee for Health Reform in Lebanon Panel Members: Dr. Fred Rosen; Chairman, Harvard Center for Blood Research, Harvard Medical School Professor Dr. Felix Harder; Chairman, Department of Surgery, University of Basel Dr. Robert Geursen; Vice President for Corporate Communications, Aventis Pharma



19:00		Farewell Gala Dinner and Opera Hotel Kronenhof, Pontresina Tchaikovsky's Opera, Eugene Onegin Singers from 5 International Opera Companies

GMF | 2.0